Earendil Labs raises $787M to power AI biotech, eyes a Hong Kong IPO
TL;DR Summary
US-headquartered but China-rooted Earendil Labs says it has raised $787 million in private funding to fuel its AI-driven biotech platform and is reportedly considering a Hong Kong listing.
- AI biotech Earendil announces huge $787M raise, is reportedly considering Hong Kong IPO Endpoints News
- Earendil Labs raises $787M to accelerate pipeline Axios
- Earendil Labs pulls in $787M as AI-designed anti-TL1A antibody heads to Phase II FirstWord Pharma
- Earendil Labs, an AI-powered drugmaker, hauls in $787M Yahoo Finance
- Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development The Manila Times
Reading Insights
Total Reads
1
Unique Readers
4
Time Saved
0 min
vs 1 min read
Condensed
67%
85 → 28 words
Want the full story? Read the original article
Read on Endpoints News